Clinical trials sponsored by China Medical University, China

Phase breakdown

Conditions studied

Recruiting trials led by China Medical University, China

• A Study Evaluating the Efficacy of PD-1 Inhibitor Combined With Denosumab and Chemotherapy in Locally Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer Patients With Driver Gene-Negative Status
  NCT07034391 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Binaural Beats for Cognitive Function in Older Adults With Mild Cognitive Impairment in Nursing Homes
  NCT07735910 · Phase: Not applicable (e.g. observational or device study) · Ages: 60 Years and older · Sex: All (male and female) · 3 locations
• Health Behavior Change in High-Risk Colorectal Cancer Individuals
  NCT07262840 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Months to 80 Months · Sex: All (male and female) · 1 location

Common questions

How many trials is China Medical University, China recruiting for?

China Medical University, China is the lead sponsor of 3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.